Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159629231> ?p ?o ?g. }
- W3159629231 endingPage "671" @default.
- W3159629231 startingPage "661" @default.
- W3159629231 abstract "Purpose of review Elevated levels of triglycerides, independent of low-density lipoprotein cholesterol (LDL-C) levels and statin therapy, are associated with heightened cardiovascular risk. Recent findings Mixed omega-3 fatty acid formulations, which contain varying amounts of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), lower triglycerides levels but trial results with omega-3 fatty acids combinations have generally been neutral for cardiovascular outcomes. In contrast, the REDUCE-IT trial with icosapent ethyl (IPE), a highly purified ethyl ester of EPA, demonstrated reduced cardiovascular risk in individuals with established atherosclerotic cardiovascular disease or diabetes with at least one additional risk factor, despite having relatively well controlled LDL-C levels but triglycerides at least 135 mg/dl while on statin therapy. IPE offers an important new avenue for cardiovascular risk management in statin-treated individuals with elevated triglycerides. Summary This review summarizes the results from outcome trials conducted with omega-3 fatty acids, differentiating between those with combinations of EPA/DHA and those with pure EPA, as well as imaging and preclinical data that help explain the different cardiovascular efficacy observed. A list of frequently asked questions with evidence-based responses is provided to assist our colleagues and their patients in the shared-decision process when considering if IPE is appropriate for cardiovascular risk reduction." @default.
- W3159629231 created "2021-05-10" @default.
- W3159629231 creator A5011703939 @default.
- W3159629231 creator A5014306017 @default.
- W3159629231 creator A5016752955 @default.
- W3159629231 creator A5040913971 @default.
- W3159629231 creator A5080334509 @default.
- W3159629231 creator A5091503436 @default.
- W3159629231 date "2021-04-29" @default.
- W3159629231 modified "2023-09-28" @default.
- W3159629231 title "The role of icosapent ethyl in cardiovascular risk reduction" @default.
- W3159629231 cites W1560062315 @default.
- W3159629231 cites W1853875009 @default.
- W3159629231 cites W1986111942 @default.
- W3159629231 cites W1993801853 @default.
- W3159629231 cites W2006551863 @default.
- W3159629231 cites W2020915011 @default.
- W3159629231 cites W2036747551 @default.
- W3159629231 cites W2064358352 @default.
- W3159629231 cites W2113680815 @default.
- W3159629231 cites W2125012558 @default.
- W3159629231 cites W2128788220 @default.
- W3159629231 cites W2142347023 @default.
- W3159629231 cites W2192223169 @default.
- W3159629231 cites W2290053204 @default.
- W3159629231 cites W2342969428 @default.
- W3159629231 cites W2473706804 @default.
- W3159629231 cites W2485118186 @default.
- W3159629231 cites W2592571300 @default.
- W3159629231 cites W2753496867 @default.
- W3159629231 cites W2785975902 @default.
- W3159629231 cites W2790714701 @default.
- W3159629231 cites W2800627035 @default.
- W3159629231 cites W2808724025 @default.
- W3159629231 cites W2899669642 @default.
- W3159629231 cites W2899720772 @default.
- W3159629231 cites W2900151286 @default.
- W3159629231 cites W2911290113 @default.
- W3159629231 cites W2918880809 @default.
- W3159629231 cites W2920910705 @default.
- W3159629231 cites W2969391566 @default.
- W3159629231 cites W2969523838 @default.
- W3159629231 cites W2973983647 @default.
- W3159629231 cites W2976844203 @default.
- W3159629231 cites W2987000681 @default.
- W3159629231 cites W2987868385 @default.
- W3159629231 cites W2991262768 @default.
- W3159629231 cites W2995193460 @default.
- W3159629231 cites W3004838676 @default.
- W3159629231 cites W3010882329 @default.
- W3159629231 cites W3013214255 @default.
- W3159629231 cites W3015405225 @default.
- W3159629231 cites W3039041541 @default.
- W3159629231 cites W3082332778 @default.
- W3159629231 cites W3086878755 @default.
- W3159629231 cites W3087299746 @default.
- W3159629231 cites W3092016772 @default.
- W3159629231 cites W3095590613 @default.
- W3159629231 cites W3099468740 @default.
- W3159629231 cites W3103257019 @default.
- W3159629231 cites W3107163014 @default.
- W3159629231 cites W3111116262 @default.
- W3159629231 cites W3183857127 @default.
- W3159629231 cites W4206654024 @default.
- W3159629231 cites W4213222556 @default.
- W3159629231 cites W4254135372 @default.
- W3159629231 cites W4292670990 @default.
- W3159629231 doi "https://doi.org/10.1097/hco.0000000000000873" @default.
- W3159629231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33929367" @default.
- W3159629231 hasPublicationYear "2021" @default.
- W3159629231 type Work @default.
- W3159629231 sameAs 3159629231 @default.
- W3159629231 citedByCount "2" @default.
- W3159629231 countsByYear W31596292312022 @default.
- W3159629231 countsByYear W31596292312023 @default.
- W3159629231 crossrefType "journal-article" @default.
- W3159629231 hasAuthorship W3159629231A5011703939 @default.
- W3159629231 hasAuthorship W3159629231A5014306017 @default.
- W3159629231 hasAuthorship W3159629231A5016752955 @default.
- W3159629231 hasAuthorship W3159629231A5040913971 @default.
- W3159629231 hasAuthorship W3159629231A5080334509 @default.
- W3159629231 hasAuthorship W3159629231A5091503436 @default.
- W3159629231 hasConcept C126322002 @default.
- W3159629231 hasConcept C134018914 @default.
- W3159629231 hasConcept C178790620 @default.
- W3159629231 hasConcept C185592680 @default.
- W3159629231 hasConcept C19038510 @default.
- W3159629231 hasConcept C2776091944 @default.
- W3159629231 hasConcept C2776839432 @default.
- W3159629231 hasConcept C2777171753 @default.
- W3159629231 hasConcept C2778163477 @default.
- W3159629231 hasConcept C2778913445 @default.
- W3159629231 hasConcept C2779134260 @default.
- W3159629231 hasConcept C2909478654 @default.
- W3159629231 hasConcept C2994242795 @default.
- W3159629231 hasConcept C3017514745 @default.
- W3159629231 hasConcept C543025807 @default.
- W3159629231 hasConcept C55493867 @default.